In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
BO-2727, a new injectable carbapenem, was evaluated for its in vitro and in vivo antibacterial activities in comparison with those of biapenem, meropenem, imipenem, cefpirome, and ceftazidime. BO-2727 had activity comparable to that of imipenem against methicillin-susceptible staphylococci and strep...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1995
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162678/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7625784/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.5.1030 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|